Roche

News

After ph3 win, Roche eyes earlier use of Columvi in DLBCL

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting

News

FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test

A blood test being developed by Roche and Eli Lilly that could help diagnose patients with Alzheimer’s disease more quickly has been awarded breakthrough status by the FDA

News

Roche gets EU okay for first HER2-low test kit

Roche has obtained a CE Mark in the EU for a companion diagnostic that can be used to identify patients with HER2-low metastatic breast cancer who may be eligible for trea

News

Lonza adds biologics capacity with $1.2bn Roche deal

Roche is set to raise $1.2 billion from the sale of a US biologics manufacturing facility to Swiss contract development and manufacturing organisation (CDMO) Lonza, part o

News

Roche’s Xolair is first medicine for food allergy in US

Fast approaching the end of its patent life, Roche and Novartis’ Xolair is going out with a bang, picking up a new approval as the first and only drug therapy for people w

News

Roche, PathAI team up on AI companion diagnostics

Roche has turned to artificial intelligence specialist PathAI to accelerate development of digital pathology technologies that can be used to match patients with drug treatments and s

After ph3 win, Roche eyes earlier use of Columvi in DLBCL

FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test

Roche gets EU okay for first HER2-low test kit

Lonza adds biologics capacity with $1.2bn Roche deal

Roche’s Xolair is first medicine for food allergy in US

Roche, PathAI team up on AI companion diagnostics

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Roche

Editor's Picks